[Neuromyelitis optica spectrum disorders positive for anti-AQP4 antibody associated with myasthenia gravis: A literature review]

J Fr Ophtalmol. 2019 Mar;42(3):e131-e132. doi: 10.1016/j.jfo.2018.06.018. Epub 2019 Feb 23.

[Article in French]

Authors

T N Brignol¹, N Leveziel², J A Urtizberea³

Affiliations

¹ Direction des actions médicales, Association française contre les myopathies (AFM-Téléthon), 1, rue de l'Internationale, BP 59, 91002 Évry cedex, France. Electronic address: tnbrignol@afm-telethon.fr.
² Inserm 1084, ophtalmologie, CHU de Poitiers, 2, rue de la Milétrie, 86021 Poitiers, France.
³ Centre de compétence maladies neuromusculaires, hôpital Marin, AP-HP, route de la Corniche, 64701 Hendaye cedex, France.

PMID: 30803764
DOI: 10.1016/j.jfo.2018.06.018

No abstract available

Publication types

Letter
Review

MeSH terms

Aquaporin 4 / immunology*
Autoantibodies / adverse effects*
Autoantibodies / blood
Comorbidity
Humans
Myasthenia Gravis / blood
Myasthenia Gravis / diagnosis*
Myasthenia Gravis / epidemiology
Myasthenia Gravis / immunology*
Neuromyelitis Optica / blood
Neuromyelitis Optica / diagnosis
Neuromyelitis Optica / epidemiology
Neuromyelitis Optica / immunology*

Substances

AQP4 protein, human
Aquaporin 4
Autoantibodies